Metropolitan Life Insurance Company (MetLife)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,212
| Closed | -$86.2K | – | 2918 |
|
|
2021
Q1 | $86.2K | Sell |
12,212
-2,280
| -16% | -$16.1K | ﹤0.01% | 2463 |
|
|
2020
Q4 | $90.7K | Sell |
14,492
-64
| -0.4% | -$401 | ﹤0.01% | 2401 |
|
|
2020
Q3 | $78.7K | Sell |
14,556
-272
| -2% | -$1.47K | ﹤0.01% | 2354 |
|
|
2020
Q2 | $77.4K | Buy |
+14,828
| New | +$77.4K | ﹤0.01% | 2397 |
|
|
2018
Q4 | – | Sell |
-14,760
| Closed | -$143K | – | 2583 |
|
|
2018
Q3 | $143K | Hold |
14,760
| – | – | ﹤0.01% | 2229 |
|
|
2018
Q2 | $151K | Buy |
14,760
+6,625
| +81% | +$67.6K | ﹤0.01% | 2112 |
|
|
2018
Q1 | $106K | Hold |
8,135
| – | – | ﹤0.01% | 2260 |
|
|
2017
Q4 | $146K | Sell |
8,135
-7,194
| -47% | -$129K | ﹤0.01% | 2093 |
|
|
2017
Q3 | $385K | Hold |
15,329
| – | – | ﹤0.01% | 1861 |
|
|
2017
Q2 | $369K | Buy |
15,329
+4,624
| +43% | +$111K | ﹤0.01% | 1919 |
|
|
2017
Q1 | $206K | Hold |
10,705
| – | – | ﹤0.01% | 2248 |
|
|
2016
Q4 | $165K | Sell |
10,705
-936
| -8% | -$14.4K | ﹤0.01% | 2461 |
|
|
2016
Q3 | $151K | Buy |
11,641
+1,028
| +10% | +$13.3K | ﹤0.01% | 2487 |
|
|
2016
Q2 | $148K | Buy |
10,613
+1,411
| +15% | +$19.7K | ﹤0.01% | 2527 |
|
|
2016
Q1 | $140K | Hold |
9,202
| – | – | ﹤0.01% | 2368 |
|
|
2015
Q4 | $175K | Hold |
9,202
| – | – | ﹤0.01% | 2345 |
|
|
2015
Q3 | $175K | Hold |
9,202
| – | – | ﹤0.01% | 2372 |
|
|
2015
Q2 | $237K | Buy |
+9,202
| New | +$237K | ﹤0.01% | 2286 |
|